These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 12777341

  • 1. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK.
    Duggan A, Warner J, Knapp M, Kerwin R.
    Br J Psychiatry; 2003 Jun; 182():505-8. PubMed ID: 12777341
    [Abstract] [Full Text] [Related]

  • 2. Suicide in schizophrenia: risk factors and clozapine treatment.
    Meltzer HY.
    J Clin Psychiatry; 1998 Jun; 59 Suppl 3():15-20. PubMed ID: 9541333
    [Abstract] [Full Text] [Related]

  • 3. The Business Case for Expanded Clozapine Utilization.
    Gören JL, Rose AJ, Smith EG, Ney JP.
    Psychiatr Serv; 2016 Nov 01; 67(11):1197-1205. PubMed ID: 27301766
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is clozapine antisuicidal?
    Kerwin RW, Bolonna AA.
    Expert Rev Neurother; 2004 Mar 01; 4(2):187-90. PubMed ID: 15853559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial.
    Meltzer HY.
    J Clin Psychiatry; 1999 Mar 01; 60 Suppl 12():47-50. PubMed ID: 10372612
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine.
    Davies LM, Barnes TR, Jones PB, Lewis S, Gaughran F, Hayhurst K, Markwick A, Lloyd H, CUTLASS Team.
    Value Health; 2008 Mar 01; 11(4):549-62. PubMed ID: 18179662
    [Abstract] [Full Text] [Related]

  • 9. Clozapine for the treatment of schizophrenia.
    Fakra E, Azorin JM.
    Expert Opin Pharmacother; 2012 Sep 01; 13(13):1923-35. PubMed ID: 22803789
    [Abstract] [Full Text] [Related]

  • 10. New vs. old antipsychotics: the Texas experience.
    Reid WH.
    J Clin Psychiatry; 1999 Sep 01; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [Abstract] [Full Text] [Related]

  • 11. The pharmacoeconomics of clozapine: a review.
    Meltzer HY, Cola PA.
    J Clin Psychiatry; 1994 Sep 01; 55 Suppl B():161-5. PubMed ID: 7961564
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, Fye C, Charney D.
    N Engl J Med; 1997 Sep 18; 337(12):809-15. PubMed ID: 9295240
    [Abstract] [Full Text] [Related]

  • 18. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
    Oh PI, Iskedjian M, Addis A, Lanctôt K, Einarson TR.
    Can J Clin Pharmacol; 2001 Sep 18; 8(4):199-206. PubMed ID: 11743592
    [Abstract] [Full Text] [Related]

  • 19. Treatment-resistant schizophrenia--the role of clozapine.
    Meltzer HY.
    Curr Med Res Opin; 1997 Sep 18; 14(1):1-20. PubMed ID: 9524789
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of atypical antipsychotics in chronic schizophrenia.
    Amin S.
    Hosp Med; 1999 Jun 18; 60(6):410-3. PubMed ID: 10492711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.